PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+14.73%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$352M
AUM Growth
+$80.2M
(+30%)
Cap. Flow
+$77.6M
Cap. Flow
% of AUM
22.07%
Top 10 Holdings %
Top 10 Hldgs %
34.86%
Holding
100
New
24
Increased
44
Reduced
21
Closed
11
Top Buys
| 1 |
Boston Scientific
BSX
|
$13.5M |
| 2 |
Eli Lilly
LLY
|
$11.4M |
| 3 |
Edwards Lifesciences
EW
|
$6.77M |
| 4 |
Haemonetics
HAE
|
$6.72M |
| 5 |
CVS Health
CVS
|
$6.11M |
Top Sells
| 1 |
Altimmune
ALT
|
$6.55M |
| 2 |
iRhythm Technologies
IRTC
|
$6.08M |
| 3 |
Avantor
AVTR
|
$5.36M |
| 4 |
908 Devices
MASS
|
$3.07M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$2.6M |
Sector Composition
| 1 | Healthcare | 96.37% |
| 2 | Industrials | 1.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Day One Biopharmaceuticals
DAWN
$766M
| $4.25M | 1.21% |
212,191
+97,441
| +85% | +$1.95M |
|
27
Procept Biorobotics
PRCT
$2.11B
| $4.2M | 1.19% |
101,201
+6,701
| +7% | +$278K |
|
28
Insulet
PODD
$24.2B
| $3.91M | 1.11% |
17,054
+3,165
| +23% | +$726K |
|
29
Sutro Biopharma
STRO
$85.6M
| $3.82M | 1.08% |
687,335
+502,817
| +273% | +$2.79M |
|
30
Thermo Fisher Scientific
TMO
$183B
| $3.8M | 1.08% |
+7,500
| New | +$3.8M |
|
31
ANI Pharmaceuticals
ANIP
$2.06B
| $3.79M | 1.08% |
117,941
+9,382
| +9% | +$302K |
|
32
Keros Therapeutics
KROS
$638M
| $3.76M | 1.07% |
99,927
+52,139
| +109% | +$1.96M |
|
33
Aclaris Therapeutics
ACRS
$223M
| $3.68M | 1.05% |
233,626
-71,217
| -23% | -$1.12M |
|
34
BioMarin Pharmaceuticals
BMRN
$11.3B
| $3.64M | 1.04% |
+42,961
| New | +$3.64M |
|
|
APEN
35
DELISTED
Apollo Endosurgery, Inc.
APEN
| $3.62M | 1.03% |
657,690
+7,690
| +1% | +$42.4K |
|
36
Arcus Biosciences
RCUS
$1.24B
| $3.61M | 1.03% |
137,894
-33,320
| -19% | -$872K |
|
37
Cogent Biosciences
COGT
$1.83B
| $3.53M | 1% |
236,697
-52,053
| -18% | -$777K |
|
|
VRNA
38
Verona Pharma
VRNA
$9.18B
| $3.3M | 0.94% |
+323,273
| New | +$3.3M |
|
|
CTLT
39
DELISTED
CATALENT, INC.
CTLT
| $3.28M | 0.93% |
45,304
-22,314
| -33% | -$1.61M |
|
40
DexCom
DXCM
$30.9B
| $3.25M | 0.92% |
40,358
+5,524
| +16% | +$445K |
|
|
41
iRhythm Technologies
IRTC
$5.67B
| $3.19M | 0.91% |
25,458
-48,543
| -66% | -$6.08M |
|
|
NSTG
42
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.1M | 0.88% |
+242,600
| New | +$3.1M |
|
43
Schrodinger
SDGR
$1.42B
| $3.09M | 0.88% |
123,679
+1,454
| +1% | +$36.3K |
|
44
Supernus Pharmaceuticals
SUPN
$2.52B
| $3.04M | 0.86% |
89,709
+1,051
| +1% | +$35.6K |
|
45
MannKind Corp
MNKD
$1.69B
| $2.86M | 0.81% |
924,979
+160,165
| +21% | +$495K |
|
|
IMGO
46
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $2.85M | 0.81% |
189,193
+41,806
| +28% | +$629K |
|
47
Intuitive Surgical
ISRG
$158B
| $2.81M | 0.8% |
+15,000
| New | +$2.81M |
|
48
Cooper Companies
COO
$13.3B
| $2.8M | 0.8% |
42,488
+488
| +1% | +$32.2K |
|
49
Lantheus
LNTH
$3.75B
| $2.79M | 0.79% |
39,682
+18,255
| +85% | +$1.28M |
|
|
KRTX
50
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.7M | 0.77% |
+12,000
| New | +$2.7M |
|